Sarthi Manjunatha, Lodha Rakesh, Vivekanandhan Subbiah, Arora Narendra K
Neurobiochemistry, Neurosciences Center, All India Institute of Medical Sciences, New Delhi, India.
Pediatr Crit Care Med. 2007 Jan;8(1):23-8. doi: 10.1097/01.pcc.0000256622.63135.90.
There is paucity of data on the magnitude of absolute or relative adrenal insufficiency in septic shock, especially in children. We conducted a prospective study to determine the prevalence of adrenal insufficiency in children with septic shock using a low-dose Synacthen (1 microg) stimulation test.
Cross-sectional study.
Pediatric intensive care unit in a tertiary care hospital in northern India.
Children with septic shock.
None.
We performed cortisol estimation at baseline and after low-dose Synacthen (1 microg) stimulation at 30 and 60 mins in children with fluid refractory septic shock admitted to our pediatric intensive care unit. Basal cortisol levels <7 microg/dL and peak cortisol level <18 microg/dL were used to define adrenal insufficiency. An increment of <9 microg/dL after stimulation was used to diagnose relative adrenal insufficiency. As there is lack of consensus on the cutoffs for defining relative adrenal insufficiency using the low-dose adrenocorticotropic hormone test, we evaluated different cutoff values (increment at 30 mins, increment at 60 mins, greater of the two increments) and evaluated their association with the incidence of catecholamine refractory shock and outcomes. Children with sepsis but without septic shock were sampled for baseline cortisol levels as a comparison. Thirty children (15 girls) with septic shock were included; median age (95% confidence interval) was 36.5 (9.39- 58.45) months. Median Pediatric Risk of Mortality score was 22.5 (14.13-24.87). Fifteen (50%) children survived. The median (95% confidence interval) cortisol values at baseline and 30 mins and 60 mins after stimulation were 71 (48.74-120.23) microg/dL, 78.1 (56.9-138.15) microg/dL, and 91 (56.17-166.44) microg/dL, respectively. The median baseline cortisol value in age- and gender-matched children with sepsis was 11.5 microg/dL. None of the children with septic shock fulfilled the criteria for absolute adrenal insufficiency. However, nine (30%) patients had relative adrenal insufficiency (increment in cortisol <9 microg/dL). Of these nine patients, five (56%) died; of the 21 patients with a greater increment in cortisol after stimulation, ten died (p = .69). Compared with patients in septic shock with normal adrenal reserve, those with relative adrenal insufficiency had a higher incidence of catecholamine refractory shock (p = .019) but no difference in mortality rate (p = .69). On the sensitivity and specificity analysis using various cutoffs of increment, the best discrimination for catecholamine refractory shock was obtained with a peak increment <6 microg/dL.
Relative adrenal insufficiency is common in children with septic shock and is associated with catecholamine refractory shock.
关于脓毒性休克中绝对或相对肾上腺功能不全的程度,尤其是儿童患者的数据较少。我们开展了一项前瞻性研究,采用低剂量辛纳肽(1微克)刺激试验来确定脓毒性休克患儿肾上腺功能不全的患病率。
横断面研究。
印度北部一家三级护理医院的儿科重症监护病房。
脓毒性休克患儿。
无。
对于入住我们儿科重症监护病房、液体复苏难治性脓毒性休克患儿,我们在基线以及低剂量辛纳肽(1微克)刺激后30分钟和60分钟时进行皮质醇测定。基础皮质醇水平<7微克/分升且峰值皮质醇水平<18微克/分升用于定义肾上腺功能不全。刺激后增量<9微克/分升用于诊断相对肾上腺功能不全。由于在使用低剂量促肾上腺皮质激素试验定义相对肾上腺功能不全的临界值方面缺乏共识,我们评估了不同的临界值(30分钟时的增量、60分钟时的增量、两者中较大的增量),并评估它们与儿茶酚胺难治性休克发生率及预后的关联。对患有脓毒症但无脓毒性休克的儿童进行基线皮质醇水平采样作为对照。纳入30例(15例女孩)脓毒性休克患儿;中位年龄(95%置信区间)为36.5(9.39 - 58.45)个月。儿科死亡风险评分中位数为22.5(14.13 - 24.87)。15例(50%)患儿存活。基线、刺激后30分钟和60分钟时皮质醇值的中位数(95%置信区间)分别为71(48.74 - 120.23)微克/分升、78.1(56.9 - 138.15)微克/分升和91(56.17 - 166.44)微克/分升。年龄和性别匹配的脓毒症患儿基线皮质醇值中位数为11.5微克/分升。没有脓毒性休克患儿符合绝对肾上腺功能不全的标准。然而,9例(30%)患者存在相对肾上腺功能不全(皮质醇增量<9微克/分升)。这9例患者中,5例(56%)死亡;在刺激后皮质醇增量较大的21例患者中,10例死亡(p = 0.69)。与肾上腺储备正常的脓毒性休克患者相比,相对肾上腺功能不全患者儿茶酚胺难治性休克的发生率更高(p = 0.019),但死亡率无差异(p = 0.69)。在使用不同增量临界值进行敏感性和特异性分析时,峰值增量<6微克/分升对儿茶酚胺难治性休克的区分效果最佳。
相对肾上腺功能不全在脓毒性休克患儿中很常见,且与儿茶酚胺难治性休克相关。